Loss of serglycin promotes primary tumor growth and vessel functionality in the rip1-tag2 mouse model for spontaneous insulinoma formation

HIGHLIGHTS

• who: Andrew Hamilton and collaborators from the Department of Medical Biochemistry and Microbiology, University have published the Article: Loss of Serglycin Promotes Primary Tumor Growth and Vessel Functionality in the RIP1-Tag2 Mouse Model for Spontaneous Insulinoma Formation, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0126688]. May 15, 2015 of October/17,/2014
• what: For the first time the authors show that serglycin-deficiency affects orthotopic primary tumor growth and tumor vascular functionality of late stage carcinomas.
• how: To further investigate the contribution of serglycin to tumor development the authors . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.